PER percheron therapeutics limited

Ann: Phase IIb study of ATL1102 in DMD completes recruitment, page-231

  1. 3,898 Posts.
    lightbulb Created with Sketch. 895
    It's the same...if we can't see and can't trade on those...it's insto or broker to broker...

    That 11 m at this stage has been spent on paper ...as technically that's for the ongoing trial to be completed.....and some working capital...

    It's not about faith in trial ..it's about the PUL numbers....if they don't show any change then they would be doing a CR at 2 c....Any management would want to play safe...

    Unless we have $20-$30m upfront payment coming from partnership...time will tell

    GL...
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
1.0¢
Change
0.000(0.00%)
Mkt cap ! $10.87M
Open High Low Value Volume
1.0¢ 1.0¢ 1.0¢ $5.737K 573.7K

Buyers (Bids)

No. Vol. Price($)
1 3633138 1.0¢
 

Sellers (Offers)

Price($) Vol. No.
1.1¢ 3174000 4
View Market Depth
Last trade - 15.22pm 17/06/2025 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.